从人类iPSC衍生的冠状细胞原生体中有效地产生冠状细胞颗粒,使用基于板状细胞的自我聚合技术
Shojiro Hanaki1, Daisuke Yamada1, Tomoka Takao1
1Department of Regenerative Science, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama 700-8558, Japan.
International journal of molecular sciences
|November 27, 2024
概括
一种新的细胞自我聚合技术 (CAT) 有效地从干细胞中产生均的状细胞颗粒,用于软骨修复. 这些粒子在动物模型中成功地集成并产生软骨矩阵,显示了骨科医学的前景.
科学领域:
- 生物医学工程 生物医学工程
- 再生医学是一种再生医学.
- 整形外科科学 整形外科科学
背景情况:
- 关节软骨具有有限的自我修复能力,这在骨科医学中构成了重大挑战.
- 开发软骨再生方法对于治疗关节损伤和疾病至关重要.
研究的目的:
- 开发一种简化且可扩展的方法,从人类诱导的多能干细胞衍生的可扩展四肢介质细胞 (ExpLBM) 中产生状细胞颗粒.
- 评估这些软骨细胞颗粒在软骨再生应用中的潜力.
主要方法:
- 在专门的CAT板 (prevelex-CAT®) 上使用细胞自我聚合技术 (CAT) 进行状细胞颗粒生产.
- 在聚合颗粒中诱导ExplLBM细胞分化为冠状细胞.
- 进行了组织学和免疫组织化学分析,以评估软骨标记物表达.
- 在免疫缺陷大鼠中,移植生成的冠状细胞颗粒进入骨髓缺陷.
主要成果:
- CAT系统以高效和一致的方式产生了大小均的状细胞颗粒.
- 产生的颗粒表达了关键的软骨标记物 (II型原蛋白,亚格格兰) 并缺乏多变性标记物 (X型原蛋白).
- 移植的颗粒在体内证明成功移植和细胞外基质的产生,通过Safranin O和Toluidine Blue染色证实了这一点.
结论:
- 基于板式的CAT系统提供了一种强大,简化和高效的方法,用于大规模的软骨细胞颗粒生产.
- 这些软骨细胞颗粒对于软骨再生疗法具有重大潜力.
- 需要进一步的研究来完善该系统,并探索对软骨缺陷的临床应用.
相关概念视频
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...


